Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (707)	4/12/2007 1:12:01 PM
From: zeta1961	Respond to of 802

My ego is the only one getting killed!..although, given DNDN's recent activity, I'm glad I didn't push the impulse buy button on Monday..Besides being quite busy lately outside of my trading life, I think that my ignorance about how the stock market works showed up here..personally, I'd never seen such a short squeeze..after the 1st day triple in gains of DNDN, I was waiting for it to take a breather..the zealous bulls over at Ivillage scared me from diving in.. Anyway, there's always another train in the distance..what concerns me about playing it even after this week's 'breather' is that the risk of conditional approval pending current trial results, is imo, a realistic outcome..yet the FDA only gives conditional approvals on surrogate endpoints..therein, lies the battle with shorts and longs at this point(I know you know this, I'm thinking out loud)..will the FDA bend this rule? and I'm not a nimble trader nor have the tools like L2, etc..